[CHRS] YoY Quarter Result on 31-Mar-2022 [#Q1]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
05-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -143.29%
YoY- 35.68%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 77,063 32,436 60,115 83,034 116,180 37,098 0 -
PBT 102,875 -75,729 -96,084 -172,947 36,505 -20,004 -44,302 -
Tax 1,464 -949 15,159 5,709 933 5,027 2,541 -8.77%
NP 102,875 -74,780 -111,243 -172,947 35,572 -20,004 -44,297 -
Tax Rate -1.42% - - - -2.56% - - -
Total Cost -25,812 107,216 171,358 255,981 80,608 57,102 44,297 -
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 133.49 -230.55 -185.05 -208.28 30.62 -53.92 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS 0.91 -0.94 -1.44 -2.37 0.50 -0.29 -0.74 -
EPS Diluted 0.82 -0.94 -1.44 -2.37 0.48 -0.29 -0.74 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.